NEJM at ESMO - Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer No … ← The Sense and Sensibility of Sensitivity Analyses NEJM at ESMO - Ponsegromab in Cancer Cachexia →